MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.08 EGP | -4.59% |
|
-17.13% | -29.49% |
| Sales 2022 | 730M 15.23M 20.82M | Sales 2023 | 526M 10.98M 15.01M | Capitalization | 1.68B 35.12M 48M |
|---|---|---|---|---|---|
| Net income 2022 | 174M 3.63M 4.97M | Net income 2023 | -273M -5.7M -7.79M | EV / Sales 2022 | 2.59 x |
| Net Debt 2022 | 16.96M 354K 484K | Net Debt 2023 | 151M 3.15M 4.31M | EV / Sales 2023 | 3.48 x |
| P/E ratio 2022 |
10.9
x | P/E ratio 2023 |
-6.1
x | Employees | - |
| Yield 2022 |
3.25% | Yield 2023 |
-
| Free-Float | 27.02% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.59% | ||
| 1 week | -17.13% | ||
| Current month | -15.79% | ||
| 1 month | -18.11% | ||
| 3 months | -32.90% | ||
| 6 months | -15.45% | ||
| Current year | -29.49% |
1 week
2.05
2.40
1 month
2.052.89
Current year
2.053.84
1 year
2.033.84
3 years
2.035.28
5 years
2.035.28
10 years
2.035.28
| Managers | Title | Age | Since |
|---|---|---|---|
Hisham Wasfy
CEO | Chief Executive Officer | - | 19-11-30 |
Ashraf Hamdy
DFI | Director of Finance/CFO | - | 19-06-30 |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sahar El-Sallab
BRD | Director/Board Member | - | 20-12-31 |
Ahmed Badreldin
BRD | Director/Board Member | 52 | 20-12-31 |
Ahmed El-Nayeb
FOU | Founder | - | 01-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 2.1 | -.--% | 664,436 |
| 24-05-01 | 2.1 | +0.96% | 762,686 |
| 24-04-30 | 2.08 | -4.59% | 963,895 |
| 24-04-29 | 2.18 | +0.93% | 431,325 |
| 24-04-28 | 2.16 | -5.26% | 560,834 |
End-of-day quote Egyptian Exchange, April 29, 2024
More quotes
Macro Group Pharmaceutical S.A.E. (Macro Capital) is specialized in developing, manufacturing and marketing pharmaceuticals. The company's products include anti-scar, skincare, antiseptic, hair care, oral care and muscle relaxant medicines. In addition, the group offers plant-based medicines.
At the end of 2021, Macro Group Pharmaceutical S.A.E. (Macro Capital) had one production site in Egypt.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.1
EGP
Average target price
5.3
EGP
Spread / Average Target
+152.38%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -29.49% | 24.71M | |
| +29.68% | 699B | |
| +25.07% | 571B | |
| -4.35% | 364B | |
| +17.65% | 326B | |
| +3.77% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.79% | 154B |
- Stock Market
- Equities
- MCRO Stock
